Stockreport

LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

LakeShore Biopharma Co., Ltd - Ordinary Shares  (LSB) 
PDF BEIJING, Sept. 22, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated [Read more]